Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

ADC Therapeutics Sarl - Product Pipeline Review - 2015

Published: Feb-2015 | Format: PDF | Global Markets Direct | Number of pages: 26 | Code: MRS - 7041

 

Global Markets Direct’s, ‘ADC Therapeutics Sarl Product Pipeline Review 2015’, provides an overview of the ADC Therapeutics Sarl’s pharmaceutical research and development focus.

 

This report provides comprehensive information on the current therapeutic developmental pipeline of ADC Therapeutics Sarl’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

 

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

 

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

 

Scope

 

The report provides brief overview of ADC Therapeutics Sarl including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of ADC Therapeutics Sarl’s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement 
Latest news and deals relating to the ADC Therapeutics Sarl’s pipeline products

 

Reasons to buy

 

Evaluate ADC Therapeutics Sarl’s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of ADC Therapeutics Sarl in its therapy areas of focus
Identify new drug targets and therapeutic classes in the ADC Therapeutics Sarl’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of ADC Therapeutics Sarl and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of ADC Therapeutics Sarl
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of ADC Therapeutics Sarl and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues

Table of Contents
 

Table of Contents 2
List of Tables 3
List of Figures 3
ADC Therapeutics Sarl Snapshot 4
ADC Therapeutics Sarl Overview 4
Key Information 4
Key Facts 4
ADC Therapeutics Sarl - Research and Development Overview 5
Key Therapeutic Areas 5
ADC Therapeutics Sarl - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Partnered Products 9
Partnered Products/Combination Treatment Modalities 10
ADC Therapeutics Sarl - Pipeline Products Glance 11
ADC Therapeutics Sarl - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
ADC Therapeutics Sarl - Drug Profiles 13
ADCT-301 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
ADCT-401 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Monoclonal Antibody Conjugates for Prostate Cancer 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
Monoclonal Antibody Conjugates for Solid Tumor and Blood Cancer 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
VM-101 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Monoclonal Antibody Conjugates for Cancer 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
ADC Therapeutics Sarl - Pipeline Analysis 19
ADC Therapeutics Sarl - Pipeline Products by Target 19
ADC Therapeutics Sarl - Pipeline Products by Molecule Type 20
ADC Therapeutics Sarl - Pipeline Products by Mechanism of Action 21
ADC Therapeutics Sarl - Recent Pipeline Updates 22
ADC Therapeutics Sarl - Dormant Projects 23
ADC Therapeutics Sarl - Locations And Subsidiaries 24
Head Office 24

 

Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 25
Disclaimer 26


List of Tables
 

ADC Therapeutics Sarl, Key Information 4
ADC Therapeutics Sarl, Key Facts 4
ADC Therapeutics Sarl - Pipeline by Indication, 2015 6
ADC Therapeutics Sarl - Pipeline by Stage of Development, 2015 7
ADC Therapeutics Sarl - Monotherapy Products in Pipeline, 2015 8
ADC Therapeutics Sarl - Partnered Products in Pipeline, 2015 9
ADC Therapeutics Sarl - Partnered Products/ Combination Treatment Modalities, 2015 10
ADC Therapeutics Sarl - Preclinical, 2015 11
ADC Therapeutics Sarl - Discovery, 2015 12
ADC Therapeutics Sarl - Pipeline by Target, 2015 19
ADC Therapeutics Sarl - Pipeline by Molecule Type, 2015 20
ADC Therapeutics Sarl - Pipeline Products by Mechanism of Action, 2015 21
ADC Therapeutics Sarl - Recent Pipeline Updates, 2015 22
ADC Therapeutics Sarl - Dormant Developmental Projects,2015 23


List of Figures
 

ADC Therapeutics Sarl - Pipeline by Top 10 Indication, 2015 6
ADC Therapeutics Sarl - Pipeline by Stage of Development, 2015 7
ADC Therapeutics Sarl - Monotherapy Products in Pipeline, 2015 8
ADC Therapeutics Sarl - Pipeline by Top 10 Molecule Type, 2015 20

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)1500 View Pricing